Jabbarpoor Bonyadi Mohammad Hossein, Yaseri Mehdi, Soheilian Masoud
Ophthalmic Research Center, Shahid Beheshti University of Medical Sciences , Tehran, Iran.
Department of Biostatistics and Epidemiology, Tehran University of Medical Sciences , Tehran, Iran.
Ophthalmic Genet. 2020 Aug;41(4):301-307. doi: 10.1080/13816810.2020.1765396. Epub 2020 May 14.
Complement factor H (CFH) Y402 H (rs1061170) and age-related maculopathy susceptibility2 (ARMS2)/LOC387715 A69 S (rs10490924) polymorphisms shown to have significant association with AMD. In this meta-analysis, we updated and pooled the results of available association studies between combined ARMS2/LOC387715A69 S-CFHY402 H genotypes and AMD to estimate the synergistic effects.
Heterogeneity of studies was evaluated using Cochran Q-test and I-square index. To modify the heterogeneity in the variables we used random effects model. Meta-analysis was performed using STATA. To estimate the additive or supra-additive effects we calculated RERI (relative excess risk due to interaction), AP (attributable proportion due to interaction), S (synergy index) and V (multiplicative index).
We included 12 studies with 4668 AMD patients and 4936 control subjects. Considering the GGTT genotypes as reference line, the pooled AMD odds ratios for stratified combined genotypes was 2.13 (95% CI 1.64-2.78) for GGnonTT, 2.17 (95% CI 1.63-2.89) for nonGGTT and 7.23 (95% CI 4.95-10.55) for nonGGnonTT. Pooled synergy analysis revealed RERI = 3.90 (95% CI 0.58-10.03), AP = .53 (95% CI 0.09-0.69), S = 2.57 (95% CI 1.27-5.22) and V = 1.47 (95% CI 1.21-1.80).
This updated analysis showed a strong synergistic and positive multiplicative effect of these two genes indicating that there is common pathway of ARMS2/LOC387715 A69 S and CFH Y402 H in AMD pathogenesis which may be complement system pathway.
补体因子H(CFH)Y402H(rs1061170)以及年龄相关性黄斑病变易感性2(ARMS2)/ LOC387715 A69S(rs10490924)多态性显示与年龄相关性黄斑变性(AMD)显著相关。在此荟萃分析中,我们更新并汇总了ARMS2/ LOC387715 A69S - CFH Y402H联合基因型与AMD之间现有关联研究的结果,以评估协同效应。
使用Cochran Q检验和I²指数评估研究的异质性。为了修正变量中的异质性,我们使用随机效应模型。使用STATA进行荟萃分析。为了评估相加或超相加效应,我们计算了RERI(交互作用所致相对超额危险度)、AP(交互作用所致归因比例)、S(协同指数)和V(相乘指数)。
我们纳入了12项研究,其中有4668例AMD患者和4936例对照受试者。将GGTT基因型作为参照系,分层联合基因型的汇总AMD比值比在GG非TT时为2.13(95%可信区间1.64 - 2.78),在非GGTT时为2.17(95%可信区间1.63 - 2.89),在非GG非TT时为7.23(95%可信区间4.95 - 10.55)。汇总协同分析显示RERI = 3.90(95%可信区间0.58 - 10.03),AP = 0.53(95%可信区间0.09 - 0.69),S = 2.57(95%可信区间1.27 - 5.22),V = 1.47(95%可信区间1.21 - 1.80)。
这项更新分析显示这两个基因具有很强的协同和正向相乘效应,表明在AMD发病机制中ARMS2/ LOC387715 A69S和CFH Y402H存在共同途径,可能是补体系统途径。